Engineering an immune receptor improves resistance to bacterial and fungal pathogens in a variety of plants https://t.co/ot1D3ixtCg
https://t.co/A73Uwz4T6d
As the @humancellatlas project enters its second decade, the question is no longer whether we can map human cells, it is what we will do with the map https://t.co/cRfYrHoRJz
An analysis of the CRISPR–Cas patent landscape is essential for understanding applications in depth and overcoming challenges strategically, thereby supporting a safer integration of CRISPR–Cas into clinical practice https://t.co/ODK4oSTKfp
https://t.co/zYm8Em9p6W
In a major step toward clinical translation, transplanting stem cells into the injured spinal cords of rhesus monkeys improves hand function #NBTNV https://t.co/WVP05QqKD3
https://t.co/bHjEnU6OA0
.@Regeneron's newly approved antibody stops abnormal bone growth in patients with the devastating disease fibrodysplasia ossificans https://t.co/0GqyO9GnlU
Ever wondered what a cell has experienced in the past? This is in general hard to measure. Here we introduce the recordanelle, to equip cells with a tool that lets them record their own history.
https://t.co/JVM3yOit8s
@NatureBiotech@ETH@randall_platt@ETH_BSSE
Our final version of human AGO2 led editing of RNA is out today in @NatureBiotech! Led by @noScandineHere, we got excited by the reduced immunogenic risk and efficacy advantages of using a human-derived protein for non-downregulatory RNA manipulation.
https://t.co/0cyURONnEH